Bonit Capital, a Swedish investment firm, provides sector-agnostic capital, focusing on digital health, medtech, and diagnostics. We also champion social innovation through impact investing.
Location
Stockholm, Stockholm County, SE
Bonit Capital is a Swedish family-owned investment firm that provides sector-agnostic capital with a focus on digital health, medical technology, and diagnostics. The firm invests across various stages, including Seed, Series A, and Series B rounds. Bonit Capital also engages in social innovation through impact investing, supporting ambitious founders and entrepreneurial teams with deep sector expertise.
Notable portfolio companies include Invicta Medical and Meru Health. Bonit Capital takes an active ownership approach, offering capital, industry expertise, and access to an international network. The firm is committed to driving innovation in life sciences and has a strong track record of supporting companies that address critical healthcare challenges, such as Astrego Sysmex, which won the £8m Longitude Prize for developing a rapid test to tackle superbugs.
Bonit Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages